| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |